Offerings
Benzinga Professional
- 8:35 AM TJX Sees Q2 Comps Up 2-3%, Sees FY Comps Up 1-2%
- 8:35 AM Multi-Color Corporation Reports Q4 EPS of $0.56 vs $0.49 Est
- 08:34 AM CytRx Offers Initial Results from Trial with Aldoxorubicin in Solid Tumors
- 8:34 AM Red Robin Sees FY13 Same-Store Sales Growth 2.5-3%
- 8:33 AM TJX Companies, Inc. (The) Sees FY2013 EPS $2.70-2.80 vs $2.82 Est
- 8:33 AM TJX Expecting Q2 EPS $0.61-0.63 vs $0.64 Est.
- 8:32 AM TJX Q1 Sales $6.19B vs $6.18B Est.
- 8:32 AM Stifel Nicolaus Maintains Buy on Carnival Corporation, Lowers PT to $40.00
- 8:32 AM Stifel Nicolaus Maintains Buy on Sabra Healthcare REIT, Inc., Raises PT to $34.00
- 8:31 AM Stifel Nicolaus Maintains Buy on Hexcel Corporation, Raises PT to $40.00
- 8:31 AM TJX Companies, Inc. (The) Reports Q1 EPS of $0.62 vs $0.63 Est
- 8:31 AM Stifel Nicolaus Initiates Coverage on Harris Corporation at Hold
- 8:30 AM DA Davidson Downgrades Comerica Incorporated to Neutral
- 8:30 AM Red Robin Gourmet Burgers, Inc. Reports Q1 EPS of $0.66, Inline; Revenue of $306.30M vs $306.22M Est
- 8:30 AM Nomura Maintains Neutral on Carnival Corporation, Lowers PT to $36.00
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- New data reinforces strength of Novartis once-daily COPD portfolio in improving lung function, shortness of breath and reducing rate of exacerbations
- Benzinga's Top Pre-Market Losers
- UPDATE: Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening
- J&J's Janssen Announces Primary Efficacy, Safety Findings from Phase 3 Study of Simeprevir Once Daily
- Benzinga's Top Upgrades
- Benzinga's Top Pre-Market Gainers
- Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
- Benzinga's Top Downgrades
- UPDATE: AutoZone FQ3 Profit Up 6.8%
- UPDATE: Best Buy Posts Upbeat Q1 Profit
- iPad 5 Production to Rise in July After Spring Trial
- The 5 Can't-Miss Apple Stories from the Past Week
- Earnings Expectations for the Week of May 20
- Microsoft's Third Xbox to be Unveiled in 24 Hours
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- The 8 Possible Changes Tumblr Users Can Expect from the Yahoo Acquisition
- Websense Signs Definitive Agreement to be Acquired by Vista Equity Partners; Shareholders to Receive $24.75 per Share in Cash in Transaction Valued at Approximately $1 Billion
- UPDATE: Bank of America Raises PT on Tesla Motors Following Equity Offering Completion
- UPDATE: Nomura Downgrades SanDisk Corporation to Neutral as Stock Approaches Target
- Barron's Recap: Cues from Cooperman